Burning Rock Biotech (BNR) Gross Margin (2019 - 2026)
Burning Rock Biotech (BNR) posted quarterly Gross Margin of 72.27% for Q1 2026, down 91.0% year-over-year from 803.03% in Q1 2025, and down 7.38% quarter-over-quarter from 78.03% in Q4 2025.
Burning Rock Biotech (BNR) Gross Margin (2019 - 2026) Analysis & Trends
Burning Rock Biotech's Gross Margin history runs 8 years deep, the most recent figure standing at 72.27% for Q1 2026.
- In Q1 2026, Gross Margin fell 91.0% year-over-year to 72.27%; the TTM figure through Mar 2026 stood at 74.56% (up 306.0% YoY), while the FY2025 annual figure was 74.67%, up 442.0% from the prior year.
- Gross Margin for Q1 2026 stood at 72.27%, down from 78.03% in the prior quarter.
- The five-year high for Gross Margin was 78.03% in Q4 2025, with the low at 63.13% in Q2 2022.
- The 5-year median for Gross Margin is 70.42% (2024), against an average of 70.08%.
- The sharpest annual moves came in 2022 and 2025: Gross Margin tumbled 777 bps in 2022, then jumped 707 bps in 2025.
- Burning Rock Biotech's Gross Margin stood at 71.2% in 2022, then slipped by 9 bps to 64.51% in 2023, then grew by 10 bps to 70.96% in 2024, then grew by 10 bps to 78.03% in 2025, then declined by 7 bps to 72.27% in 2026.
- Business Quant data shows BNR's Gross Margin at 72.27% in Q1 2026, 78.03% in Q4 2025, and 75.1% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 69.57% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 57.64% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 64.04% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 53.95% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 32.85% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 99.91% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 66.44% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 63.29% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 33.75% |
| 10 | Burning Rock Biotech | 781.17 Mn | 711.04 Mn | 11.31 Mn | 72.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72.27% |
| Dec 31, 2025 | 78.03% |
| Sep 30, 2025 | 75.10% |
| Jun 30, 2025 | 72.77% |
| Mar 31, 2025 | 73.18% |
| Dec 31, 2024 | 70.96% |
| Sep 30, 2024 | 71.40% |
| Jun 30, 2024 | 70.42% |
| Mar 31, 2024 | 68.21% |
| Dec 31, 2023 | 64.51% |
| Sep 30, 2023 | 67.35% |
| Jun 30, 2023 | 68.65% |
| Mar 31, 2023 | 69.30% |
| Dec 31, 2022 | 71.20% |
| Sep 30, 2022 | 70.23% |
| Jun 30, 2022 | 63.13% |
| Mar 31, 2022 | 64.62% |
| Dec 31, 2021 | 71.52% |
| Sep 30, 2021 | 72.34% |
| Jun 30, 2021 | 70.89% |